Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Multi-component Exercise on Mild Cognitive Impairment In Elderly Population

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03938051
Recruitment Status : Completed
First Posted : May 6, 2019
Last Update Posted : September 6, 2019
Sponsor:
Information provided by (Responsible Party):
Riphah International University

Brief Summary:
Participants will be randomized to exercise intervention and control groups, for 6 weeks. The participants will be examined for following test Mini mental state examination, Trail making test A and B, MOCA. The intervention will consist of twice weekly, 55- 60 minute exercise session for experimental group The participants of control group will receive 20 minutes treadmill walk thrice weekly. Participants will walk at constant pace with zero inclination such that a subjective rate of perceived of 5 to 7 points on the ten-point Borg scale will be reached. Assessment of both groups will be done on first session and on last session.

Condition or disease Intervention/treatment Phase
Mild Cognitive Impairment Other: Experimental group Other: Control group Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 51 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Primary Purpose: Treatment
Official Title: Effects of Multicomponent Exercise on Mild Cognitive Impairment In Elderly Population ,a Randomized Control Trial
Actual Study Start Date : January 15, 2019
Actual Primary Completion Date : June 30, 2019
Actual Study Completion Date : July 12, 2019

Arm Intervention/treatment
Experimental: Experimental group
Multi-component intervention
Other: Experimental group
Multicomponent intervention for twice weekly 55-60 minutes 6 weeks

Experimental: Control group
treadmill walk
Other: Control group
20 minutes treadmill walk thrice weekly, 5-7 /10 subjective rate of perceived exertion




Primary Outcome Measures :
  1. Mini mental state examination (MMSE) [ Time Frame: 6 week ]
    Changes from the Baseline, Mini mental state examination (MMSE): used to screen for cognitive impairment in elderly. It is as 30-point questionnaire. The reliability of the MMSE, ranging from 0.76 to 0.90.

  2. Trail making test (TMT) A & B [ Time Frame: 6 week ]
    Changes from the Baseline, Trail making test (TMT) A & B: It is a test of visual attention and task switching. It provides information about visual search speed, speed of processing and executive function. The test reliability for TMT (A -B) is 0.82 and 0.93. Time will be measured in seconds

  3. Montreal cognitive assessment (MoCA) [ Time Frame: 6 week ]
    Changes from the Baseline, Montreal cognitive assessment (MoCA): it is used widely for screening cognitive impairment.The test re-test reliability for MOCA is 0.966. Scoring. MoCA scores range between 0 and 30. A score of 26 or over is considered to be normal. In a study, normal people scored an average of 27.4; people with mild cognitive impairment (MCI) scored an average of 22.1; people with Alzheimer's disease scored an average of 16.2.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   55 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Both men and women
  • Mini-Mental State Examination (MMSE) score 18- 23 (mild cognitive impairment)

Exclusion Criteria:

  • Had current medical condition for which exercise is contraindicated
  • Had neurodegenerative disease /stroke
  • Oncologic patient with active treatment with chemotherapy
  • Patient with arterial diseases in the past 12 months

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03938051


Locations
Layout table for location information
Pakistan
Riphah International University
Islamabad, Federal, Pakistan, 44000
Sponsors and Collaborators
Riphah International University
Investigators
Layout table for investigator information
Principal Investigator: Imran Amjad, PHD* Riphah International University
Layout table for additonal information
Responsible Party: Riphah International University
ClinicalTrials.gov Identifier: NCT03938051    
Other Study ID Numbers: RiphahIU Hafsah Gul Khattak
First Posted: May 6, 2019    Key Record Dates
Last Update Posted: September 6, 2019
Last Verified: September 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Riphah International University:
Exercise
Mild Cognitive Impairment
Elderly Population
Additional relevant MeSH terms:
Layout table for MeSH terms
Cognitive Dysfunction
Cognition Disorders
Neurocognitive Disorders
Mental Disorders